<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aberrant activation of the Wnt/β-catenin pathway occurs in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This review presents several important <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related aspects of Wnt/β-catenin signalling relevant to the epididymis, provides evidence of such epididymal gene expression and suggests a new direction for further research </plain></SENT>
<SENT sid="2" pm="."><plain>The data presented here indicate that besides containing many Wnt/β-catenin-pathway components, the <z:mpath ids='MPATH_458'>normal</z:mpath> adult human epididymis expresses much more β-catenin than the colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cell line HCT116, which possesses elevated β-catenin expression </plain></SENT>
<SENT sid="3" pm="."><plain>The low <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence in the epididymis may be due to factors present in the human epididymis that regulate this oncogenic Wnt/β-catenin pathway, including (i) 14 of 17 secreted pathway inhibitors, (ii) the majority of the micro-<z:chebi fb="40" ids="33697">RNAs</z:chebi> known to target this pathway, (iii) plasma membrane-associated E-cadherin and CEACAM1 that anchor β-catenin, preventing its availability for nuclear entry and oncogenic transcriptional activity, (iv) the recently identified membrane-located <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e> inhibitors RNF43 and ZNRF3 that mediate the degradation of the Wnt receptor components Fzds and Lrp5/6 and (v) nuclear KLF4, which competes with TCF for β-catenin, limiting its transcriptional activity and stabilizing telomeres, thereby reducing mutation incidence </plain></SENT>
<SENT sid="4" pm="."><plain>The above regulatory factors expressed by the human epididymis, and the absence of <z:chebi fb="3" ids="50113">androgen</z:chebi> receptor translocation known to promote nuclear translocation of β-catenin in <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e> in an animal model, may act synergistically to provide hostility in different cell compartments towards <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> formation </plain></SENT>
<SENT sid="5" pm="."><plain>The lack of evidence for β-catenin in epididymal nuclei is noteworthy </plain></SENT>
<SENT sid="6" pm="."><plain>Studying this phenomenon may help reveal the mechanisms underlying oncogenic Wnt/β-catenin signalling and shed new light on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy and prevention </plain></SENT>
</text></document>